Amplia Therapeutics Limited logo

Amplia Therapeutics Limited

ASX:ATX.AX

Overview | Financials
Company Name Amplia Therapeutics Limited
Symbol ATX.AX
Currency AUD
Price 0.285
Market Cap 110,566,605
Dividend Yield 0%
52-week-range 0.049 - 0.425
Industry Biotechnology
Sector Healthcare
CEO Dr. Christopher J. Burns B.Sc., BSc(Hons), Ph.D.
Website https://www.ampliatx.com

An error occurred while fetching data.

About Amplia Therapeutics Limited

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has

Related Stocks

ECS Botanics Holdings Ltd logo

ECS Botanics Holdings Ltd

ECS.AX

0.01 AUD

ImExHS Limited logo

ImExHS Limited

IME.AX

0.255 AUD

Immuron Limited logo

Immuron Limited

IMC.AX

0.064 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD